Colorado

Psychedelic trials in Colorado

26 registered trials has a study site in Colorado, and 5 are recruiting now.

Trials with a site here

Recruiting

Facilities

Open now

Recruiting in this state

Trial	Status	Phase	Substance	Sites
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)NCT07592689 · Definium Therapeutics US, Inc.	Recruiting	Phase 3	lsd	30
Psilocybin Therapy in Advanced CancerNCT05398484 · NYU Langone Health	Recruiting	Phase 2 / Phase 3	psilocybin	2
Investigation to Understand and Optimize PsilocybinNCT06512194 · Charles Raison	Recruiting	Phase 2	psilocybin	1
Safety and Tolerability Trial of Psilocybin in Healthy Older AdultsNCT07516405 · University of Colorado, Denver	Recruiting	Phase 1	psilocybin	6
Study of Psilocybin Assisted Psychotherapy to Address Fear of RecurrenceNCT06430541 · University of Colorado, Denver	Recruiting	Phase 1	psilocybin	2

Facilities

Where the research happens in Colorado

Facility	City	Trials
Wholeness Center	Fort Collins	5
Mountain View Clinical Research	Denver	3
Aguazul-Blue Water Inc.	Boulder	3
Mountain View Clinical Research, Inc	Denver	2
Vail Health Behavioral Health	Edwards	2
University of Colorado Anschutz Medical Campus	Aurora	2
Aguazul Bluewater, Inc.	Boulder	2
Denver Health Medical Center	Denver	2
University of Colorado Anschutz Medical campus (CU AMC)	Aurora	1
Outpatient CTRC	Aurora	1
University of Colorado Cancer Center	Aurora	1
Rocky Mountain Regional VA Medical Center, Aurora, CO	Aurora	1
University of Colorado Hospital	Aurora	1
University of Colorado	Aurora	1
Starlight Clinical Research	Evergreen	1
Mountain View	Denver	1
Memoru	Boulder	1
Clinical Site 145	Denver	1
Offices of Marcela d'Otalora	Boulder	1
University of Colorado Denver	Aurora	1

Stay told

When a trial opens in Colorado

All trials

Every trial with a Colorado site

Trial	Status	Phase	Substance	Sites
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)NCT07592689 · Definium Therapeutics US, Inc.	Recruiting	Phase 3	lsd	30
Psilocybin Therapy in Advanced CancerNCT05398484 · NYU Langone Health	Recruiting	Phase 2 / Phase 3	psilocybin	2
Investigation to Understand and Optimize PsilocybinNCT06512194 · Charles Raison	Recruiting	Phase 2	psilocybin	1
Safety and Tolerability Trial of Psilocybin in Healthy Older AdultsNCT07516405 · University of Colorado, Denver	Recruiting	Phase 1	psilocybin	6
Study of Psilocybin Assisted Psychotherapy to Address Fear of RecurrenceNCT06430541 · University of Colorado, Denver	Recruiting	Phase 1	psilocybin	2
VA Aripiprazole vs Esketamine for Treatment Resistant DepressionNCT05554627 · VA Office of Research and Development	Withdrawn	Phase 4	ketamine	26
Ketamine vs. Placebo as Adjunctive Therapies for Severe Alcohol WithdrawalNCT02823977 · University of Colorado, Denver	Withdrawn	Phase 4	ketamine	1
A Randomized, Double-Blind Study of Placebo vs. Ketamine For Use During Dressing Changes in Critically Ill Burn PatientsNCT02336308 · University of Colorado, Denver	Withdrawn	Phase 4	ketamine	1
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"NCT06564818 · Cybin IRL Limited	Active, not recruiting	Phase 3	psilocybin	45
A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)NCT06941844 · Definium Therapeutics US, Inc.	Active, not recruiting	Phase 3	lsd	22
Psilocybin for Major Depressive Disorder (MDD)NCT06308653 · Usona Institute	Active, not recruiting	Phase 3	psilocybin	29
A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)NCT06741228 · Definium Therapeutics US, Inc.	Active, not recruiting	Phase 3	lsd	34
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)NCT03537014 · Resilient Pharmaceuticals	Completed	Phase 3	mdma	15
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)NCT04077437 · Resilient Pharmaceuticals	Completed	Phase 3	mdma	14
A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSDNCT04714359 · Resilient Pharmaceuticals	Completed	Phase 3	mdma	15
Psilocybin for Treatment-Resistant DepressionNCT06230757 · University of Colorado, Denver	Completed	Phase 2	psilocybin	1
MDMA-Assisted Therapy for Stress Disorders in Healthcare Workers and First RespondersNCT05455996 · Nautilus Sanctuary	Not yet recruiting	Phase 2	mdma	3
A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety SymptomsNCT05407064 · Definium Therapeutics US, Inc.	Completed	Phase 2	lsd	22
A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO StudyNCT04103892 · Clexio Biosciences Ltd.	Completed	Phase 2	ketamine	46
Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSDNCT01793610 · Resilient Pharmaceuticals	Completed	Phase 2	mdma	1
Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSDNCT03282123 · Resilient Pharmaceuticals	Completed	Phase 2	mdma	12
A Study of Ketamine in Patients With Treatment-resistant DepressionNCT01627782 · Janssen Research & Development, LLC	Completed	Phase 2	ketamine	13
Psilocybin Effects on Healthy Aging Biomarkers and Purpose in LifeNCT07719088 · Charles Raison	Not yet recruiting	Phase 1	psilocybin	1
Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy VolunteersNCT01404754 · Resilient Pharmaceuticals	Completed	Phase 1	mdma	3
Inpatient Single Dose Interventions for Alcohol Use DisorderNCT04562779 · Denver Health and Hospital Authority	Completed	Early Phase 1	ketamine	1
Effect of Ketamine and Etomidate During RSI on Long Term OutcomesNCT06179485 · Vanderbilt University Medical Center	Enrolling by invitation	N/A	ketamine	6

Site locations from ClinicalTrials.gov API v2, data build 2026-08-25.

Elsewhere